A new research report published by Infinium Global Research
identified that the global Psoriasis Therapeutics market is set to grow on the
backdrop of rising population of psoriasis population and more promising drugs
in pipeline. The growth in this market is also supported by factors such as
increasing availability of diagnostic procedures, lifestyle changes and
endeavors by the drug manufactures to meet the unmet needs. The global market
size of Psoriasis Therapeutics was USD 6.74 billion in 2016 and it is projected
to reach to USD 12.97 billion in 2023 growing at a CAGR of 9.7% between 2017
and 2023.
Get Sample Copy of this Report: https://www.infiniumglobalresearch.com/Reports/MakeSampleRequest/825
Americas
region led the global Psoriasis Therapeutics market, which is attributable to
the growing prevalence of the psoriasis in the U.S. and Canada and presence of
large companies operating in this market in the region. Moreover, high level of
awareness among the people about the use of Psoriasis Therapeutics in the U.S.
is a primary driver promoting the growth in this region. Asia-Pacific region is
expected to grow at the highest rate over the next six years owing to rapid
lifestyle changes among the consumers in India, and China. Moreover, growing
healthcare expenditure among the population in the Asia Pacific region is
likely to act a major driver in the region.
Biologics dominate the global market for psoriasis diagnostics
According to
the report the global market for psoriasis diagnostics is dominated by
biologics as a choice for treatment. Enbrel, Humira, and Remicade are among the
approved biologic drugs presently used in the treatment of psoriasis. Moreover,
several biologic drugs in the pipeline are likely to escalate the demand for
biologics for the purpose of treatment of psoriasis over the forecast
period. In addition, the raising
awareness about psoriasis among the patients is likely to augment the market
size psoriasis diagnostics in the years to come.
Make
an Enquiry: https://www.infiniumglobalresearch.com/Reports/MakeEnquiryRequest/825
The
report segments the global Psoriasis Therapeutics market as:
Global Psoriasis Therapeutics Market by Molecule 2017
- 2023
·
Biologics
·
Small
Molecules
Global Psoriasis Therapeutics Market by Route of
Administration 2017 -
2023
·
Oral
·
Parenteral
Global Psoriasis Therapeutics Market by Dosage forms
2017 - 2023
·
Solid
·
Liquid
·
Semi-solid
Global Psoriasis Therapeutics Market by Mechanism of
Action 2017 - 2023
·
TNF
Inhibitors
·
PDE4
Inhibitors
·
IL
blocker
·
Others
Companies profiled in the report
·
Amgen,
Inc.
·
Johnson
&
Johnson
·
Eli
Lilly and Company
·
AstraZeneca
·
Novartis
AG
·
AbbVie
Inc.
·
Celgene
Corporation
·
Other
companies in this market
